Cme (CME) Liabilities and Shareholders Equity (2009 - 2026)

Cme (CME) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $194.7 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 8.21% year-over-year to $194.7 billion; the TTM figure through Jun 2026 stood at $782.2 billion (up 27.61% YoY), while the FY2025 annual figure was $198.4 billion, up 44.36% from the prior year.
• Liabilities and Shareholders Equity declined to $194.7 billion in Q2 2026 per CME's latest filing, from $202.0 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $205.9 billion in Q1 2022 and bottomed at $123.4 billion in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $164.4 billion across 5 years, with a median of $170.1 billion in 2022.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity fell 29.61% — and 2025, when it jumped 45.82%.
• Cme's Liabilities and Shareholders Equity stood at $174.2 billion in 2022, then dropped by 25.53% to $129.7 billion in 2023, then grew by 5.97% to $137.4 billion in 2024, then jumped by 44.36% to $198.4 billion in 2025, then slipped by 1.89% to $194.7 billion in 2026.
• Business Quant data shows CME's Liabilities and Shareholders Equity at $194.7 billion in Q2 2026, $202.0 billion in Q1 2026, and $198.4 billion in Q4 2025.